Coronary heart disease: the female heart is vulnerable.

Abstract:

:During the past decade, an overall theme has emerged, validating the exploration of gender-based differences in coronary heart disease (CHD) as a basis for clinical strategies to improve outcomes for women. Underrepresentation of women in most of CHD and lack of gender-specific reporting in many clinical trials continue to limit the available knowledge and evidence-based medicine needed to devise optimal managements for women with CHD. Control of conventional coronary risk factors provides comparable cardioprotection for men and women. Current evidence fails to show cardiac protection from menopausal hormone therapy. Clinical presentations of coronary heart disease (CHD) and management strategies differ between the sexes. Underutilization of proven beneficial therapies is a contributor to less-favorable outcomes in women. The contemporary increased application of appropriate diagnostic, therapeutic, and interventional managements has favorably altered the prognosis for women, particularly when the data are adjusted for baseline characteristics. Better education of women during office visits, earlier and more aggressive control of coronary risk factors, and a greater index of suspicion regarding chest pain and its appropriate evaluation may help to reverse the trend of late referral and late intervention. Research indicates that behavioral changes on the part of women and reshaping of practice patterns by their health care providers may dramatically reduce the number of women disabled and killed by CHD each year.

journal_name

Prog Cardiovasc Dis

authors

Wenger NK

doi

10.1016/j.pcad.2003.08.003

subject

Has Abstract

pub_date

2003-11-01 00:00:00

pages

199-229

issue

3

eissn

0033-0620

issn

1873-1740

pii

S0033062003001166

journal_volume

46

pub_type

杂志文章,评审
  • Transcranial Doppler assessment of cerebral embolic disorders.

    abstract::Transcranial Doppler ultrasound allows noninvasive monitoring of the large intracranial vessels. Microembolic signals (MES) have been observed under a variety of circumstances, especially in symptomatic carotid stenosis, high-risk cardiac conditions, and surgical procedures (such as carotid endarterectomy and cardiopu...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1053/pcad.2000.9028

    authors: Gorman M

    更新日期:2000-09-01 00:00:00

  • The current global state of movement and physical activity - the health and economic costs of the inactive phenotype.

    abstract::Physical inactivity is one of the major contributing factors to the global pandemic of non-communicable diseases. Unfortunately, low levels of habitual movement and physical activity (PA) are seen in an increasing proportion of populations across low- and middle-income countries and high-income countries alike. This n...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2020.10.006

    authors: Jayasinghe S,Byrne NM,Patterson KAE,Ahuja KDK,Hills AP

    更新日期:2020-10-30 00:00:00

  • Noninvasive assessment of atherosclerosis.

    abstract::The application of ultrasound to clinical evaluation of the symptomatic patient requires less precision and accuracy than when it is used as an instrument to study atherogenesis. The clinician's goal is to locate hemodynamically significant lesions; studies of atherogenesis require auxometry (measurement of the growth...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章

    doi:10.1016/0033-0620(84)90007-0

    authors: Blankenhorn DH,Rooney JA,Curry PJ

    更新日期:1984-01-01 00:00:00

  • Economic impact of mechanical cardiac assistance.

    abstract::In contrast to heart transplantation, little effort has been made to estimate the economic implications of mechanical cardiac assistance from either a procedure- or a program-level perspective. With annual direct and indirect expenditures for the treatment of coronary artery disease and congestive heart failure now ex...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1053/pcad.2000.7201

    authors: Evans RW

    更新日期:2000-07-01 00:00:00

  • Cardiac rehabilitation in India.

    abstract::Cardiovascular diseases (CVDs) are the leading cause of death and disability in India. Moreover, mortality following an acute myocardial infarction is high, which may be due to gaps in secondary prevention in general and a lack of cardiac rehabilitation (CR) services in particular. This review discusses the availabili...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2013.11.001

    authors: Madan K,Babu AS,Contractor A,Sawhney JP,Prabhakaran D,Gupta R

    更新日期:2014-03-01 00:00:00

  • Peripheral circulation in arterial hypertension.

    abstract::The underlying causes of hypertensive disease remain unclear. This article has attempted to highlight potential dysfunctions in arterial pressure regulation which could either initiate or sustain the hypertensive process. As has been suggested innumerable times hypertension must certainly be a multifactorial abnormali...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/0033-0620(76)90001-3

    authors: Brody MJ,Zimmerman BG

    更新日期:1976-03-01 00:00:00

  • The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: a global perspective.

    abstract::The Framingham Heart Study has been a trailblazer in the field of cardiovascular epidemiology. The wealth of novel scientific data that it has generated over 5 decades has made a significant contribution to cardiovascular disease (CVD) prevention in the United States and indirectly influenced global CVD prevention str...

    journal_title:Progress in cardiovascular diseases

    pub_type: 历史文章,杂志文章

    doi:10.1016/j.pcad.2010.01.001

    authors: Mendis S

    更新日期:2010-07-01 00:00:00

  • Precision Medicine, Healthy Living and the Complex Patient: Managing the Patient With Multimorbidity.

    abstract::Multimorbidity is the most common chronic health condition in adults and is associated with poor health outcomes. Optimal care for people with multimorbidity requires a person-centred approach that considers goals and preferences, improves quality of life and coordinates care across services. Because care is focused o...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.12.010

    authors: Holland AE,Lee AL

    更新日期:2019-01-01 00:00:00

  • Pacemaker hemodynamics: clinical implications.

    abstract::Our review of the current literature and experience in caring for pacemaker patients suggests that a consideration of hemodynamics is a logical way to approach pacemaker selection and programming. Multiple clinical factors enter into the selection of a pacemaker or pacemaker programming settings in each case. It appea...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/0033-0620(92)90039-3

    authors: Buckingham TA,Janosik DL,Pearson AC

    更新日期:1992-03-01 00:00:00

  • Transcatheter repair of tricuspid regurgitation with MitraClip.

    abstract::Transcatheter therapy with the MitraClip system (Abbott Structural, Menlo Park, CA) is the most commonly used transcatheter therapy for patients with tricuspid regurgitation, with over 1000 cases performed worldwide. The procedure is an off-label approach that requires meticulous attention to anatomical features obtai...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2019.10.001

    authors: Sorajja P,Cavalcante JL,Gossl M,Bae R

    更新日期:2019-01-01 00:00:00

  • Catheter-based therapies for massive pulmonary embolism.

    abstract::Massive pulmonary embolism carries a high mortality rate as a result of right ventricular failure. In addition to anticoagulation, systemic thrombolysis is the standard first line of therapy for patients with life-threatening massive pulmonary embolism. Surgical embolectomy is often considered in patients with contrai...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2010.01.002

    authors: Todoran TM,Sobieszczyk P

    更新日期:2010-03-01 00:00:00

  • The Current Global State of Key Lifestyle Characteristics: Health and Economic Implications.

    abstract::The chronic disease crisis we currently face must be addressed in rapid fashion. Cardiovascular (CV) and pulmonary diseases, diabetes as well as several forms of cancer are leading causes of morbidity and mortality globally. Collectively, these conditions have a significant impact on the quality of life of individuals...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2017.02.002

    authors: Arena R,McNeil A,Sagner M,Hills AP

    更新日期:2017-01-01 00:00:00

  • Heart Failure Transitions of Care: A Pharmacist-Led Post-Discharge Pilot Experience.

    abstract:OBJECTIVE:To perform a pilot evaluation of a pharmacist-led, multidisciplinary transitional care clinic for heart failure (HF) patients. BACKGROUND:Transitions of care in HF should include: medication reconciliation, multidisciplinary care, early post-discharge follow-up, and prompt intervention on HF signs and sympto...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章

    doi:10.1016/j.pcad.2017.08.005

    authors: Milfred-LaForest SK,Gee JA,Pugacz AM,Piña IL,Hoover DM,Wenzell RC,Felton A,Guttenberg E,Ortiz J

    更新日期:2017-01-01 00:00:00

  • The economics of smoking and cardiovascular disease.

    abstract::The direct medical cost of cardiovascular and circulatory diseases was $151 billion in 1995, approximately 17% of all direct medical care costs in the United States. Incidence and prevalence based estimates indicate that smoking is a major contributing factor for cardiovascular disease and associated costs. Statewide ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(03)00077-x

    authors: Lightwood J

    更新日期:2003-07-01 00:00:00

  • Pathophysiological basis of syncope and neurological conditions that mimic syncope.

    abstract::The definition of syncope has clinical and pathophysiological parts. The clinical part is that syncope is a form of transient loss of consciousness (TLOC), while the pathophysiological element is that syncope differs from other forms of TLOC by virtue of the basis of true syncope - specifically cerebral hypoperfusion....

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2012.10.016

    authors: van Dijk JG,Wieling W

    更新日期:2013-01-01 00:00:00

  • Initial Assessment and Triage of the Stroke Patient.

    abstract::Nearly 800,000 strokes occur in the United States each year, and stroke is the leading cause of preventable permanent disability. Timely recognition and treatment are imperative to reduce stroke-related morbidity and mortality. Given the evidence supporting intravenous thrombolysis and mechanical thrombectomy for isch...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2017.04.004

    authors: Zweifler RM

    更新日期:2017-01-01 00:00:00

  • Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

    abstract::Dual antiplatelet therapy (DAPT) has been the cornerstone of antithrombotic management for patients undergoing percutaneous coronary intervention (PCI). However, approximately 10% of these patients have concomitant atrial fibrillation (AF) and require chronic oral anticoagulant (OAC) in addition to DAPT. This traditio...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.01.008

    authors: Kerneis M,Talib U,Nafee T,Daaboul Y,Pahlavani S,Pitliya A,Furqan MM,Datta S,Kazmi HA,Younes A,Gibson CM

    更新日期:2018-01-01 00:00:00

  • Positron-emitting myocardial blood flow tracers and clinical potential.

    abstract::Positron-emitting myocardial flow radiotracers such as (15)O-water, (13)N-ammonia and (82)Rubidium in conjunction with positron-emission-tomography (PET) are increasingly applied in clinical routine for coronary artery disease (CAD) detection, yielding high diagnostic accuracy, while providing valuable information on ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2015.01.001

    authors: Schindler TH

    更新日期:2015-05-01 00:00:00

  • Baroreflex function in hypertension: consequences for antihypertensive therapy.

    abstract::Studies performed in experimental animal models of hypertension as well as in human hypertension have unequivocally shown that reflex cardiovascular control undergoes profound changes with high blood pressure and participates throughout direct and indirect mechanisms at the development and progression of hypertension-...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2006.03.002

    authors: Grassi G,Trevano FQ,Seravalle G,Scopelliti F,Mancia G

    更新日期:2006-05-01 00:00:00

  • Electrophysiological basis of QT dispersion measurements.

    abstract::Dispersion of ventricular repolarization is a now widely used term describing nonhomogeneous recovery of excitability or heterogeneity of ventricular repolarization. It is usually expressed as the difference or the range of various repolarization measurements obtained from a heart. Experimentally, an increased dispers...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1053/pcad.2000.0420311

    authors: Franz MR,Zabel M

    更新日期:2000-03-01 00:00:00

  • Functional anatomy and pathophysiologic principles in mitral regurgitation: Non-invasive assessment.

    abstract::Mitral regurgitation (MR) is the most prevalent cause of valvular heart disease (VHD) in western countries. In the Euro Heart Survey on VHD, MR was the second most common heart VHD requiring surgery. It is also the most common form of VHD in community and population-based studies from the United States. The categoriza...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2017.11.008

    authors: Maréchaux S,Illman JE,Huynh J,Michelena HI,Nkomo VT,Tribouilloy C

    更新日期:2017-01-01 00:00:00

  • Diagnosis and treatment of high density lipoprotein deficiency.

    abstract::Low serum high density lipoprotein cholesterol level (HDL-C) <40 mg/dL in men and <50 mg/dL in women is a significant independent risk factor for cardiovascular disease (CVD), and is often observed in patients with hypertriglyceridemia, obesity, insulin resistance, and diabetes. Patients with marked deficiency of HDL-...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2016.08.006

    authors: Schaefer EJ,Anthanont P,Diffenderfer MR,Polisecki E,Asztalos BF

    更新日期:2016-01-01 00:00:00

  • Clinical laboratory testing: what is the role of tilt-table testing, active standing test, carotid massage, electrophysiological testing and ATP test in the syncope evaluation?

    abstract::The first step in the diagnostic evaluation of patients with suspected syncope begins with an "initial evaluation" consisting of careful history taking, physical examination including orthostatic blood pressure measurement and electrocardiogram. However, even in expert centers the diagnostic yield of this "initial eva...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2012.11.002

    authors: Blanc JJ

    更新日期:2013-01-01 00:00:00

  • Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management.

    abstract::First isolated in the early 1960s, doxorubicin (DOX) remains among the most effective anticancer drug ever developed. However, this drug has proven to be a double-edged sword because it also causes a cardiomyopathy that leads to a form of congestive heart failure that is usually refractory to common medications. It is...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2006.10.002

    authors: Takemura G,Fujiwara H

    更新日期:2007-03-01 00:00:00

  • Impact of obesity and weight loss on cardiac performance and morphology in adults.

    abstract::Obesity, particularly severe obesity is capable of producing hemodynamic alterations that predispose to changes in cardiac morphology and ventricular function. These include increased cardiac output, left ventricular hypertrophy and diastolic and systolic dysfunction of both ventricles. Facilitated by co-morbidities s...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2013.09.003

    authors: Alpert MA,Omran J,Mehra A,Ardhanari S

    更新日期:2014-01-01 00:00:00

  • Epidemiology, risk factors, and consequences of obstructive sleep apnea and short sleep duration.

    abstract::We will review the epidemiology, risk factors, and consequences of obstructive sleep apnea (OSA) and short/long sleep duration. Obstructive sleep apnea is a disease characterized by recurrent upper airway obstruction during sleep. Obstructive sleep apnea is common, with moderate to severe disease present in approximat...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2008.08.001

    authors: Al Lawati NM,Patel SR,Ayas NT

    更新日期:2009-01-01 00:00:00

  • Implications of cost-effectiveness analyses of lipid-lowering therapies: From the policy-maker's desk to the patient's bedside.

    abstract::In our increasingly cost-conscious health system, patients, clinicians, hospitals, and payers all agree about the urgent need to rein in runaway healthcare costs. High pharmaceutical costs make drugs unaffordable to many patients who may benefit from them, including some insured patients who face prohibitive out-of-po...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2019.10.006

    authors: Kazi DS,Virani SS

    更新日期:2019-01-01 00:00:00

  • Management of trastuzumab-related cardiac dysfunction.

    abstract::Trastuzumab is the standard of care for the treatment of patients with ERB2-positive breast cancer. In a minority of patients, trastuzumab is associated with an increased incidence of cardiac dysfunction that ranges from asymptomatic decreases in left ventricular ejection fraction to symptomatic heart failure. In tria...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2010.07.001

    authors: Carver JR

    更新日期:2010-09-01 00:00:00

  • Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium?

    abstract::Tumor necrosis factor alpha (TNF-alpha), a protein belonging to the family of cytokines, is one of the leading mediators of the immune response to inflammation. Its widespread biological effects are modulated by two circulating binding proteins corresponding to the extracellular domain of the membrane receptors, namel...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(98)80028-5

    authors: Ceconi C,Curello S,Bachetti T,Corti A,Ferrari R

    更新日期:1998-07-01 00:00:00

  • Advanced Imaging Techniques for Mitral Regurgitation.

    abstract::Mitral regurgitation (MR) is one of the most commonly encountered valvular lesions in clinical practice. MR can be either primary (degenerative) or secondary (functional) depending on the etiology of MR and the pathology of the mitral valve (MV). Echocardiography is the primary diagnostic tool for MR and is key in det...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.10.001

    authors: Quien MM,Vainrib AF,Freedberg RS,Bamira DG,Benenstein RJ,Williams MR,Saric M

    更新日期:2018-01-01 00:00:00